Irritable bowel syndrome in Iran: SEPAHAN Systematic Review No. 1

International Journal of Preventive Medicine

Volumn 3, Issue 4, 2012, Pages

  Jahangiri, Pegah ^a   Jazi, Marsa Sadat Hashemi ^a   Keshteli, Ammar Hassanzadeh ^a   Sadeghpour, Shirin ^a   Amini, Ehssan ^a   Adibi, Peyman ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Epidemiology; Functional gastrointestinal disorders; Irritable bowel syndrome; Systematic review Iran

Indexed keywords

ADULT; ARTICLE; DISEASE CLASSIFICATION; FEMALE; GROUPS BY AGE; HEALTH SURVEY; HUMAN; INCIDENCE; INTERVIEW; IRAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; SEX DIFFERENCE; SYSTEMATIC REVIEW;

EID: 84865253159     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006 Apr;130(5):1480-91.
2. DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006 Apr;130(5):1377-90.
3. Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin North Am. 2005 Jun;34(2):189-204.
4. Ghoshal UC, Abraham P, Bhatt C, Choudhuri G, Bhatia SJ, Shenoy K, et al. Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. Indian journal of gastroenterology: official journal of the Indian Society of Gastroenterology. 2008;27(1):22.
5. Danivat D, Tankeyoon M, Sriratanaban A. Prevalence of irritable bowel syndrome in a non- Western population. British medical journal (Clinical research ed). 1988;296(6638):1710.
6. Saito YA, Schoenfeld P, Locke III GR. The epidemiology of irritable bowel syndrome in North America: a systematic review. The American journal of gastroenterology. 2002;97(8):1910-5.
7. Hungin A, Whorwell P, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Alimentary pharmacology & therapeutics. 2003;17(5):643-50.
8. Gwee KA, Wee S, Wong ML, Png DJC. The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an Asian urban community. The American journal of gastroenterology. 2004;99(5):924-31.
9. Miwa H. Prevalence of irritable bowel syndrome in Japan: internet survey using Rome III criteria. Patient preference and adherence. 2008;2:143.
10. Mahmoudi S, Pourshams A, Akbari M, Malekzadeh R. The prevalence of irritable bowel syndrome and gastroesophageal reflux disease among Tehran University students. GOVARESH JOURNAL. 2003.
11. Pourshams A, Zendehdel N, Semnani M, Semnani Y. Irritable Bowel Syndrme and Psychatric Disordesrs among Unibersity Freshmen. Govaresh Journal. 2006.
12. Hatami K, Pourshams A, Azimi K, SARRAF M, Mehrabani M, Mostajabi P, et al. Dyspepsia, gastroesophageal reflux disease and irritable bowel syndrome among blood donors. Govaresh Journal. 2003.
13. Sorouri M, Pourhoseingholi MA, Vahedi M, Safaee A, Moghimi-Dehkordi B, Pourhoseingholi A, et al. Functional bowel disorders in Iranian population using Rome III criteria. Saudi J Gastroenterol. 2010 Jul-Sep;16(3):154-60.
14. Ganji A, Malekzadeh F, Safavi M, Nassri-Moghaddam S, Nourie M, Merat S, et al. Digestive and Liver Disease Statistics in Iran. Middle East Journal of Digestive Diseases (MEJDD). 2011;1(2):56-62.
15. Hulisz D. The burden of illness of irritable bowel syndrome: current challenges and hope for the future. Journal of Managed Care Pharmacy. 2004;10(4):299-309.
16. Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther. 2004 Nov;20 Suppl 7:31-9.
17. Whitehead WE, Palsson OS, Levy RR, Feld AD, Turner M, Von Korff M. Comorbidity in irritable bowel syndrome. The American journal of gastroenterology. 2007;102(12):2767-76.
18. NJ. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil. 2008 May;20 Suppl 1:121-9.
19. Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology. 1995;109(6):1736-41.
20. Nyrop K, Palsson O, Levy R, Korff M, Feld A, Turner M, et al. Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Alimentary pharmacology & therapeutics. 2007;26(2):237-48.
21. Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, et al. The burden of selected digestive diseases in the United States***. Gastroenterology. 2002;122(5):1500-11.
22. Shaheen NJ, Hansen RA, Morgan DR, Gangarosa LM, Ringel Y, Thiny MT, et al. The burden of gastrointestinal and liver diseases. The American journal of gastroenterology. 2006;101(9):2128-38.
23. Roshandel D, Rezailashkajani M, Shafaee S, Zali MR. A cost analysis of functional bowel disorders in Iran. International journal of colorectal disease. 2007;22(7):791-9.
24. Adibi P, Keshteli AH, Esmaillzadeh A, Afshar H, Roohafza H, Bagherian H, Daghaghzadeh H, Soltanian N, Feinle-Bisset C, Boyce P, Talley NJ. The Study on the Epidemiology of Psychological, Alimentary Health and Nutrition (SEPAHAN): overview of methodology. J Res Med Sci. 2012; [In Press]
25. Mansour Ghanaei F, Falah M, Pourrasouli Z, Ghasemipour R, Joukar Farahnaz HP, Arami M, et al. Irritable Bowel Syndrome (IBS) Prevalence in Medical Students of Gilan University of Medical Sciences. Govaresh journal. 2006.
26. Semnani S, Abdolahi N, Roshandel G, Besharat S, Keshtkar AA, Jabbari A, et al. Irritable Bowel Syndrome in Iranian Young Adults: A Survey among Medical Students. J Med Sci. 2006;6(6):974-8.
27. Ganji A, Safavi M, Nourie M, Nassri-Moghaddam S, Merat S, Vahedi H, et al. Digestive and Liver Disease Statistics in Several Referal Centers in Tehran, 2000-2004. Govaresh. 2006;11(1):33-7.
28. Majid S, Mohammad P, Mohsen V, Azadeh S, Bijan MD, Asma P, et al. Functional bowel disorders in Iranian population using Rome III criteria. Saudi Journal of Gastroenterology. 2010;16.
29. Hamdi K, Bastani P, Hashemi H, Sh P, Fattahi K. Study on the prevalence of Irritable Bowel Syndrome in patients with preterm labor. Pejouhesh. 2008;32(2):165-8.
30. Khoshbaten M, Syah Melli M, Jabar Fattahi M, Sharifi N, Mostafavi SA, Pourhoseingholi MA. Irritable bowel syndrome in women undergoing hysterectomy and tubular ligation. Gastroenterology and Hepatology from bed to bench. 2011;4(3).
31. Nikpour S, Vahedi E. COMPARISON OF IRRITABLE BOWEL SYNDROME (IBS) IN GASTRO ESOPHAGEAL REFLUX DISEASE (GERD) PATIENTS WITH AND WITHOUT ESOPHAGITIS. PEJOUHANDEH. 2007.
32. Bagheri Lankarani K, Kordjori J, Agah S, Taghavi S, Roodgari A, Afrookhteh S. Irritable bowel syndrome: Clinical manifestations and relation to Lactase deficiency. Iranian Journal of medical sciences. 1997:1-2.
33. Fadai M, Krim AQA. The prevalence of Irritable Bowel Syndrome among high school pupile in Gorgan, North of Iran. Journal of Gorgan University of Medical Sciences. 2010;11(4):76-81.
34. Ghannadi K, Emami R, Bashashati M, Tarrahi MJ, Attarian S. Irritable bowel syndrome: an epidemiological study from the west of Iran. Indian journal of gastroenterology: official journal of the Indian Society of Gastroenterology. 2005;24(5):225.
35. Hoseini-Asl M, Amra B. Evaluation of symptoms of irritable bowel synrome and its relation to some risk factors in above 20 years old females, Shahrekord, 2002. J Shahrekord Univ Med Sci 2003, 5(1): 52-62.
36. Hoseini-Asl MK, Amra B. Prevalence of irritable bowel syndrome in Shahrekord, Iran. Indian J Gastroenterol. 2003;22(6):215-6.
37. Khademolhosseini F, Mehrabani D, Nejabat M, Beheshti M, Heydari ST, Mirahmadizadeh A, et al. Irritable bowel syndrome in adults over 35 years in Shiraz, southern Iran: prevalence and associated factors. JRMS. 2011;16(2):200-6.
38. Khoshkrood-Mansoori B, Pourhoseingholi MA, Safaee A, Moghimi-Dehkordi B, Sedigh-Tonekaboni B, Pourhoseingholi A, et al. Irritable bowel syndrome: a population based study. J Gastrointestin Liver Dis. 2009;18(4):413-8.
39. Mansour-Ghanaei F, Fallah M, Heidarzadeh A, Jafarshad R, Joukar F, Ghasemipour R, et al. Prevalence and Characteristics of Irritable Bowel Syndrome (IBS) amongst Medical Students of Gilan Northern Province of Iran. Middle East Journal of Digestive Diseases (MEJDD). 2011;1(2):100-5.
40. Masoumi S, Moradi F, Mehrabani D, Khademolhosseni F, Mostaghni A, Zare N, et al. Prevalence and Quality of Life in Qashqai Migrating Nomads with Irritable Bowel Syndrome in Southern Iran. Iranian Red Crescent Medical Journal. 2009;11(4):403-7.
41. Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H. Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. European journal of gastroenterology & hepatology. 1995;7(5):427.
42. Roshandel D, Rezailashkajani M, Shafaee S, Zali MR. Symptom patterns and relative distribution of functional bowel disorders in 1,023 gastroenterology patients in Iran. International journal of colorectal disease. 2006;21(8):814-25.
43. SEMNANI S, ROUSHANDEL GHR, BESHARAT S, KESHTKAR A, MORADI A, ZENDEHBAD A, et al. Irritable bowel syndrome in students of Golestan University of Medical Sciences. GOVARESH JOURNAL. 2007.
44. Sohrabi S, Nouraie M, Khademi H, Baghizadeh S, Nasseri-Moghaddam S, Malekzadeh R. Epidemiology of uninvestigated gastrointestinal symptoms in adolescents: a population-based study applying the Rome II questionnaire. Journal of pediatric gastroenterology and nutrition. 2010;51(1):41.
45. Solhpour A, Pourhoseingholi MA, Soltani F, Zarghi A, Habibi M, Zali MR. Gastrooesophageal reflux disease and irritable bowel syndrome: a significant association in an Iranian population. Eur J Gastroenterol Hepatol. 2008 Aug;20(8):719-25.
46. Yarandi SS, Nasseri-Moghaddam S, Mostajabi P, Malekzadeh R. Overlapping gastroesophageal reflux disease and irritable bowel syndrome: increased dysfunctional symptoms. World journal of gastroenterology: WJG. 2010;16(10):1232.
47. Amini M, Karimi Zarchi AA. Evaluating the prevalence of symptoms of Irritabale Bowel Syndrome and effective factors on medical students. Journal of Medical Council of Islamic Republic of IRAN. 2005;23(2):130-136.
48. Manning A, Thompson W, Heaton K, Morris A. Towards positive diagnosis of the irritable bowel. British Medical Journal. 1978;2(6138):653-4.
49. Hillila MT, Farkkila MA. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. Aliment Pharmacol Ther. 2004 Aug 1;20(3):339-45.
50. Park DW, Lee OY, Shim SG, Jun DW, Lee KN, Kim HY, et al. The differences in prevalence and sociodemographic characteristics of irritable bowel syndrome according to Rome II and Rome III. Journal of Neurogastroenterology and Motility. 2010;16(2):186.
51. Shen L, Kong H, Hou X. Prevalence of irritable bowel syndrome and its relationship with psychological stress status in Chinese university students. Journal of gastroenterology and hepatology. 2009;24(12):1885-90.
52. Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. The American journal of gastroenterology. 1998;93(10):1816-22.
53. Rajendra S, Alahuddin S. Prevalence of irritable bowel syndrome in a multi-ethnic Asian population. Alimentary pharmacology & therapeutics. 2004;19(6):704-6.
54. Masud M, Hasan M, Khan AKA. Irritable bowel syndrome in a rural community in Bangladesh: prevalence, symptoms pattern, and health care seeking behavior. The American journal of gastroenterology. 2001;96(5):1547-52.
55. Shah S, Bhatia S, Mistry F. Epidemiology of dyspepsia in the general population in Mumbai. Indian journal of gastroenterology: official journal of the Indian Society of Gastroenterology. 2001;20(3):103.
56. Thompson W. Irritable bowel syndrome: pathogenesis and management. Lancet. 1993;341(8860):1569.
57. Payne S. Sex, gender, and irritable bowel syndrome: making the connections. Gend Med. 2004 Aug;1(1):18-28.
58. Grundmann O, Yoon SL. Irritable bowel syndrome: Epidemiology, diagnosis and treatment: An update for health-care practitioners. Journal of gastroenterology and hepatology. 2010;25(4):691-9.
59. Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. Bmj. 1997;314(7083):779.
60. Jones R, Lydeard S. Irritable bowel syndrome in the general population. British Medical Journal. 1992;304(6819):87-90.
61. Thompson W, Heaton K, Smyth G, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut. 2000;46(1):78.
62. Longstreth GF, Bolus R, Naliboff B, Chang L, Kulich KR, Carlsson J, et al. Impact of irritable bowel syndrome on patients' lives: development and psychometric documentation of a disease-specific measure for use in clinical trials. Eur J Gastroenterol Hepatol. 2005 Apr;17(4):411-20.
63. Howell S, Talley NJ, Quine S, Poulton R. The irritable bowel syndrome has origins in the childhood socioeconomic environment. The American journal of gastroenterology. 2004;99(8):1572-8.
64. Wigington WC, Johnson WD, Minocha A. Epidemiology of irritable bowel syndrome among African Americans as compared with whites: a population-based study. Clinical Gastroenterology and Hepatology. 2005;3(7):647-53.
65. Ahmed A, Mohamed RA, Sliem HA, Eldein HN. Pattern of irritable bowel syndrome and its impact on quality of life in primary health care center attendees, Suez governorate, Egypt. Pan African Medical Journal. 2011;9(1).
66. Moghimi-Dehkordi B, Vahedi M, Pourhoseingholi Ma, Khoshkrood Mansoori B, Safaee A, Habibi M, et al. Economic burden attributable to functional bowel disorders in Iran: A cross-sectional population-based study. Journal of Digestive Diseases. 2011;12(5):384-92.